| 000 | 01905 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515144138.0 | ||
| 264 | 0 | _c20090417 | |
| 008 | 200904s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdn630 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan den Wyngaert, T | |
| 245 | 0 | 0 |
_aInitial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cFeb 2009 |
||
| 300 |
_a331-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Infective Agents, Local _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadverse effects |
| 650 | 0 | 4 |
_aChlorhexidine _xtherapeutic use |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aJaw _xpathology |
| 650 | 0 | 4 |
_aJaw Diseases _xchemically induced |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNecrosis _xchemically induced |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOsteonecrosis _xchemically induced |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aClaeys, T | |
| 700 | 1 | _aHuizing, M T | |
| 700 | 1 | _aVermorken, J B | |
| 700 | 1 | _aFossion, E | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 20 _gno. 2 _gp. 331-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdn630 _zAvailable from publisher's website |
| 999 |
_c18415596 _d18415596 |
||